AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.
Clinical trial NCT02511106 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02511106
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-21
- Primary completion
- 2022-04-11
- Enrollment
- 682
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.